Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

BioSeed 2026

London, United Kingdom | 8 June 2026
Overview

Connect with Quotient Sciences’ experts who will be attending BioSeed in London on 8th June, 2026.

Meet our Business Development team to learn more about our expanded capabilities and how we can help you with your next project.  

You can schedule a partnering meeting with our experts by using the button below.  

Request a meeting with us:
Location
etc.venues 8 Fenchurch Place
EC3M 4PB
London, United Kingdom

Meet our expert:

We look forward to meeting you at the BioSeed 2026 this June.

Charlotte Hannigan

Director, Business Development

Charlotte Hannigan is a Director of Business Development at Quotient Sciences. She plays a key role in supporting the company’s mi...

About Charlotte

More insight from our experts:

Read More
Drug Product, Commercial Manufacturing, Clinical Trial Manufacturing, Translational Pharmaceutics, Regulatory, Orphan Rare, FDA Navigating Expedited Drug Development Pathways Globally: Q&A with Quotient Sciences Experts
Read More
Drug Development Consulting, Translational Pharmaceutics, Formulation Development, Drug Product, Careers The Strategic Role of Drug Development Consultants at Quotient Sciences
Read More